24 October 2022

Shield Presents Data at ACG Annual Scientific Meeting 2022 on Accrufer®

Shield Therapeutics plc (LSE: STX), announces that a pooled analysis from ferric maltol clinical trials will be presented at the American College of Gastroenterology Annual Scientific Meeting (ACG 2022).

ACG 2022 is underway, virtually and in-person, and runs through to 26 October 2022 in Charlotte, North Carolina, USA. The abstract is available online in the ACG 2022 Abstract Guide: acgmeetings.gi.org

For further details click here

Back to News